Advances in the Study of Liver Cancer Stem Cells

Liver cancer is one of the deadliest cancers in the world, and liver cancer stem cells (LCSCs) is a key factor in liver cancer pathogenesis, treatment resistance and disease recurrence. Despite significant advances in the understanding of LCSCs over the past few years, their role in liver cancer pathology remains a challenge. This review addresses the characterization of LCSCs in hepatocellular carcinoma, methods of identification, therapeutic strategies, and how they affect disease progression and patient prognosis. This paper pays special attention to recent studies on molecular markers, signaling pathways, and gene expression characterization of LCSCs. The paper also evaluates a variety of potential therapeutic approaches, including targeted drug therapies against specific signaling pathways, cell surface markers, etc., immunotherapeutic strategies such as CAR-T cell therapy, and tumor vaccines. Although most of these therapeutic strategies are still in the research phase, they offer new hope for the treatment of liver cancer. Finally, this paper discusses the challenges faced in translating these laboratory studies into clinical treatments, as well as potential directions for future research.